WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016096933) MASITINIB COMBINATION FOR USE IN TREATING BREAST CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/096933    International Application No.:    PCT/EP2015/079907
Publication Date: 23.06.2016 International Filing Date: 15.12.2015
IPC:
A61K 31/497 (2006.01), A61P 35/00 (2006.01), A61K 45/06 (2006.01), A61K 31/7068 (2006.01), A61K 31/282 (2006.01), A61K 31/704 (2006.01), A61K 31/4745 (2006.01), A61K 31/136 (2006.01)
Applicants: AB SCIENCE [FR/FR]; 3 avenue George V 75008 Paris (FR)
Inventors: MOUSSY, Alain; (FR).
KINET, Jean-Pierre; (US).
MANSFIELD, Colin; (FR)
Agent: ICOSA; 83 avenue Denfert-Rochereau 75014 Paris (FR)
Priority Data:
14198065.6 15.12.2014 EP
Title (EN) MASITINIB COMBINATION FOR USE IN TREATING BREAST CANCER
(FR) MASITINIB COMBINÉ À UTILISER DANS LE TRAITEMENT DU CANCER DU SEIN
Abstract: front page image
(EN)The present invention relates to a method for treating breast cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a tyrosine kinase inhibitor (e.g. masitinib) or a pharmaceutically acceptable salt or solvate thereof, in combination with a therapeutically effective amount of a chemotherapeutic agent.
(FR)La présente invention concerne une méthode de traitement du cancer du sein chez un sujet qui en a besoin, comprenant l'administration au sujet d'une quantité thérapeutiquement efficace d'un inhibiteur de la tyrosine kinase (ex. masitinib) ou d'un sel pharmaceutiquement acceptable ou d'un solvate de celui-ci, combiné à une quantité thérapeutiquement efficace d'un agent chimiothérapeutique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)